학술논문

Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors
Document Type
article
Source
Antimicrobial Agents and Chemotherapy. 66(10)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Clinical Sciences
Biotechnology
Malaria
Rare Diseases
Infectious Diseases
Vector-Borne Diseases
Genetics
Development of treatments and therapeutic interventions
5.1 Pharmaceuticals
Good Health and Well Being
Humans
Antimalarials
Asparagine
Drug Resistance
Ethylenediamines
Malaria
Falciparum
Peptides
Plasmodium falciparum
Proteasome Endopeptidase Complex
Proteasome Inhibitors
Uganda
antimalarial agents
proteasome
Microbiology
Pharmacology and Pharmaceutical Sciences
Medical microbiology
Pharmacology and pharmaceutical sciences
Language
Abstract
The proteasome is a promising target for antimalarial chemotherapy. We assessed ex vivo susceptibilities of fresh Plasmodium falciparum isolates from eastern Uganda to seven proteasome inhibitors: two asparagine ethylenediamines, two macrocyclic peptides, and three peptide boronates; five had median IC50 values